ATE509027T1 - Enzymatische synthese von grossen mengen von mucin glyconjugaten und deren immunogenische anwendungen - Google Patents

Enzymatische synthese von grossen mengen von mucin glyconjugaten und deren immunogenische anwendungen

Info

Publication number
ATE509027T1
ATE509027T1 AT06290091T AT06290091T ATE509027T1 AT E509027 T1 ATE509027 T1 AT E509027T1 AT 06290091 T AT06290091 T AT 06290091T AT 06290091 T AT06290091 T AT 06290091T AT E509027 T1 ATE509027 T1 AT E509027T1
Authority
AT
Austria
Prior art keywords
mucin
glyconjugates
large amounts
enzymatic synthesis
applications
Prior art date
Application number
AT06290091T
Other languages
English (en)
Inventor
Sylvie Bay
Teresa Freire
Claude Leclerc
Richard Lo-Man
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE509027T1 publication Critical patent/ATE509027T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06290091T 2006-01-13 2006-01-13 Enzymatische synthese von grossen mengen von mucin glyconjugaten und deren immunogenische anwendungen ATE509027T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06290091A EP1808442B1 (de) 2006-01-13 2006-01-13 Enzymatische Synthese von grossen Mengen von Mucin Glyconjugaten und deren immunogenische Anwendungen

Publications (1)

Publication Number Publication Date
ATE509027T1 true ATE509027T1 (de) 2011-05-15

Family

ID=36160509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06290091T ATE509027T1 (de) 2006-01-13 2006-01-13 Enzymatische synthese von grossen mengen von mucin glyconjugaten und deren immunogenische anwendungen

Country Status (8)

Country Link
US (1) US9657074B2 (de)
EP (1) EP1808442B1 (de)
JP (1) JP5231247B2 (de)
AT (1) ATE509027T1 (de)
CA (1) CA2631582C (de)
ES (1) ES2366552T3 (de)
PL (1) PL1808442T3 (de)
WO (1) WO2007079783A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008007941A1 (en) * 2006-07-10 2008-01-17 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Gainac specific binding molecules and uses thereof
CA2729567C (en) * 2008-06-30 2018-04-24 Kyowa Hakko Kirin Co., Ltd. Anti-cd27 antibody
US9588121B2 (en) 2009-11-06 2017-03-07 Go Therapeutics, Inc. Method for early detection of cancer
AU2010339359A1 (en) * 2009-12-29 2012-07-26 Kyowa Hakko Kirin Co., Ltd. Anti-CD27 antibody
CN102296052B (zh) * 2011-08-17 2013-04-10 上海交通大学 一种针对ppGalNAc-T13多克隆抗体的特异性抗原肽及其制备与应用
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
EP2843412B1 (de) 2012-04-27 2018-01-03 Konica Minolta, Inc. Antigennachweisverfahren unter verwendung von lectin mit einem enzymbehandlungsschritt
JP6323463B2 (ja) 2013-12-27 2018-05-16 コニカミノルタ株式会社 診断用情報の分析方法およびそのためのキット
US10371704B2 (en) 2013-12-27 2019-08-06 Konica Minolta, Inc. Method for discriminating between prostate cancer and a benign prostate disease
MX2017006167A (es) 2014-11-12 2018-03-23 Siamab Therapeutics Inc Compuestos que interactúan con glicanos y métodos de uso.
CA3002097A1 (en) 2015-11-12 2017-05-18 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
KR20240044544A (ko) 2017-03-03 2024-04-04 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법
EP4041773A1 (de) * 2019-10-11 2022-08-17 Beth Israel Deaconess Medical Center, Inc. Anti-tn-antikörper und verwendungen davon
CN119060186B (zh) * 2024-10-24 2025-10-24 福州迈新生物技术开发有限公司 抗Mucin6蛋白单克隆抗体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660834A (en) 1988-03-11 1997-08-26 The Biomembrane Institute Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates
EP0969873B1 (de) 1997-03-27 2006-06-07 Institut Pasteur Multiple,kohlenhydrathaltige glycopeptid-antigene, daraus entwickelte impfstoffe sowie deren verwendung
EP0996455B1 (de) 1997-04-16 2009-12-16 Sloan-Kettering Institute For Cancer Research Alpha o-gebundene glykokonjugate mit gehäuften (2,6)-st-epitopen, verfahren zur herstellung und verwendung
WO2000059540A1 (en) * 1999-04-05 2000-10-12 Biocrystal Ltd. Assay kits and methods for immune complex-mediated activation involving shed antigens
US20060150262A1 (en) * 2003-02-05 2006-07-06 Jadwiga Bienkowska Novel mucin-like polypeptides
WO2006045116A2 (en) * 2004-10-20 2006-04-27 The Scripps Research Institute In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria

Also Published As

Publication number Publication date
EP1808442B1 (de) 2011-05-11
JP5231247B2 (ja) 2013-07-10
PL1808442T3 (pl) 2011-12-30
JP2009523137A (ja) 2009-06-18
CA2631582A1 (en) 2007-07-19
EP1808442A1 (de) 2007-07-18
WO2007079783A1 (en) 2007-07-19
US9657074B2 (en) 2017-05-23
US20100272707A1 (en) 2010-10-28
ES2366552T3 (es) 2011-10-21
CA2631582C (en) 2014-04-08

Similar Documents

Publication Publication Date Title
PL1808442T3 (pl) Enzymatyczna synteza glikokoniugatów mucyny na dużą skalę i ich zastosowanie immunogenne
PT1928882E (pt) (s)-n-metilnaltrexona, processo para a sua síntese e sua utilização farmacêutica
ATE493893T1 (de) Feste enymformulierungen und verfahren zu deren herstellung
ATE528012T1 (de) Uronsäure und probiotika
CY1117563T1 (el) Αντισωματα κατα her3 και χρησεις αυτων
CY1109084T1 (el) Προϊον ζαχαροπλαστικης με χαμηλα λιπαρα
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
BRPI1010637A2 (pt) suplementos nutricionais orais compreendendo probióticos
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
ECSP099403A (es) Formulacion parenteral del anticuerpo abeta
CY1110812T1 (el) Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
BRPI0918641A8 (pt) Produtos infantis pró-bióticos.
PT1913001E (pt) (r)-n-metilnaltrexona, processos para a sua síntese e sua utilização farmacêutica
BRPI0416141B8 (pt) anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina
MX2010002723A (es) Produccion de moleculas mediante organismos fotosinteticos.
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
ATE502038T1 (de) Azyklische amininhibitoren von nukleosidphosphorylasen und hydrolasen
WO2009073153A3 (en) Small molecule myristate inhibitors of bcr-abl and methods of use
EA200801571A1 (ru) Композиции, содержащие молекулы ctl4-ig, и способы их получения
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
NO20082699L (no) Immunoglobuliner
CR11179A (es) Anticuerpos humanizados contra el globometro ab (20-42) y sus usos
TW200642700A (en) Chemically defined stabiliser
UY30927A1 (es) Miembros de union para moleculas ige

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties